Pharming Group N.V. Cash And Cash Equivalents
Pharming Group N.V. (PHAR) had Cash And Cash Equivalents of $145.31 million as of 2025-12-31, per its 20-F filed 2026-04-02.
Financial Statements › Notes
ifrs-full:CashAndCashEquivalents · last filed 2026-04-02
- 2020-12-31: Cash And Cash Equivalents 167.07M EUR.
- 2019-12-31: Cash And Cash Equivalents 66.30M EUR.
- 2018-12-31: Cash And Cash Equivalents 80.31M EUR.
- 2017-12-31: Cash And Cash Equivalents 58.66M EUR.
EUR
| Period end | Cash And Cash Equivalents |
|---|---|
| 2020-12-31 | 167.07M EUR 20-F · filed 2021-04-07 |
| 2019-12-31 | 66.30M EUR 20-F · filed 2021-04-07 |
| 2018-12-31 | 80.31M EUR 20-F · filed 2021-04-07 |
| 2017-12-31 | 58.66M EUR 20-F · filed 2021-04-07 |
USD
| Period end | Cash And Cash Equivalents |
|---|---|
| 2025-12-31 | $145.31M 20-F · filed 2026-04-02 |
| 2024-12-31 | $54.94M 20-F · filed 2026-04-02 |
| 2023-12-31 | $61.74M 20-F · filed 2026-04-02 |
| 2022-12-31 | $207.34M 20-F · filed 2026-04-02 |
| 2021-12-31 | $191.92M 20-F · filed 2025-04-03 |
| 2020-12-31 | $205.16M 20-F · filed 2024-04-04 |
| 2019-12-31 | $74.35M 20-F · filed 2023-04-05 |
| 2018-12-31 | $91.87M 20-F · filed 2022-04-06 |